Prognostic value of Bcl-2 in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy

被引：0
|
作者：
Vargas-Roig, L. M.
Cuello-Carrion, F. D.
Fernandez-Escobar, N.
Daguerre, P.
Leuzzi, M.
Ibarra, J.
Gago, F. E.
Nadin, S. B.
Ciocca, D. R.
机构：
[1] Consejo Nacl Invest Cient & Tecn, Inst Med & Expt Biol Cuyo, Mendoza, Argentina
[2] Luis Lagomaggiore Hosp, Mendoza, Argentina
[3] Natl Univ Cuyo, Sch Med, Mendoza, Argentina
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.602
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
602
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prognostic value of Bcl-2 in breast cancer patients treated with neoadjuvant anthracycline based chemotherapy
    Vargas-Roig, Laura M.
    Cuello-Carrion, F. Dario
    Fernandez-Escobar, Nicolas
    Daguerre, Pedro
    Leuzzi, Marcela
    Ibarra, Jorge
    Gago, Francisco E.
    Nadin, Silvina B.
    Ciocca, Daniel R.
    MOLECULAR ONCOLOGY, 2008, 2 (01) : 102 - 111
  • [2] Prognostic value of XIAP and survivin expression in locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy
    Pluta, Piotr
    Jesionek-Kupnicka, Dorota
    Pluta, Agnieszka
    Brzozowski, Kamil
    Braun, Marcin
    Kubicka-Wolkowska, Joanna
    Piekarski, Janusz
    ARCHIVES OF MEDICAL SCIENCE, 2023, 19 (02) : 343 - 354
  • [3] Prognostic significance of Bcl-2 expression in non-basal triple-negative breast cancer patients treated with anthracycline-based chemotherapy
    Choi, Jung Eun
    Kang, Su Hwan
    Lee, Soo Jung
    Bae, Young Kyung
    TUMOR BIOLOGY, 2014, 35 (12) : 12255 - 12263
  • [4] Prognostic implication of HSPA (HSP70) in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy
    Nadin, Silvina B.
    Sottile, Mayra L.
    Montt-Guevara, Maria M.
    Gauna, Gisel V.
    Daguerre, Pedro
    Leuzzi, Marcela
    Gago, Francisco E.
    Ibarra, Jorge
    Dario Cuello-Carrion, F.
    Ciocca, Daniel R.
    Vargas-Roig, Laura M.
    CELL STRESS & CHAPERONES, 2014, 19 (04): : 493 - 505
  • [5] Prognostic implication of HSPA (HSP70) in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy
    Silvina B. Nadin
    Mayra L. Sottile
    Maria M. Montt-Guevara
    Gisel V. Gauna
    Pedro Daguerre
    Marcela Leuzzi
    Francisco E. Gago
    Jorge Ibarra
    F. Darío Cuello-Carrión
    Daniel R. Ciocca
    Laura M. Vargas-Roig
    Cell Stress and Chaperones, 2014, 19 : 493 - 505
  • [6] Docetaxel and anthracycline-based neoadjuvant chemotherapy in breast cancer
    Tiezzi, D. G.
    Andrade, J. M.
    Macchetti, A. H.
    Clagnan, W. S.
    Marana, H. R.
    Zola, F. E.
    Peria, F. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy
    Marcella Mottolese
    Maria Benevolo
    Girolamo Del Monte
    Simonetta Buglioni
    Paola Papaldo
    Cecilia Nisticò
    Franco Di Filippo
    Stefania Vasselli
    Patrizia Vici
    Claudio Botti
    Journal of Cancer Research and Clinical Oncology, 2000, 126 : 722 - 729
  • [8] Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy
    Mottolese, M
    Benevolo, M
    Del Monte, G
    Buglioni, S
    Papaldo, P
    Nisticò, C
    Di Filippo, F
    Vasselli, S
    Vici, P
    Botti, C
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000, 126 (12) : 722 - 729
  • [9] THE VALUE OF PMAPK AND PAKT IN HER2+BREAST CANCER WITH ANTHRACYCLINE-BASED NEOADJUVANT CHEMOTHERAPY
    Huang, L.
    Chen, T.
    Chen, C.
    Chen, S.
    Liu, Y.
    Wu, J.
    Shao, Z.
    BREAST, 2013, 22 : S60 - S60
  • [10] Clinical significance of Smac and survivin expression in breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy
    Zhao, Ying-Chun
    Wang, Yan
    Ni, Xiao-Jian
    Li, Yong
    Wang, Xiu-Ming
    Zhu, Yong-Yun
    Luo, Chuan-Yu
    MOLECULAR MEDICINE REPORTS, 2014, 9 (02) : 614 - 620
12345